INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Targeted Modalities: Trends, Challenges, CDMO Considerations
Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.
-
Adaptable By Design: RTSM That Absorbs Protocol Change Via Configuration
Learn how forward-looking requirements, testing, and planning for cohort, dose-level, and supply changes can build greater flexibility into RTSM design.
-
Why Trial Expertise Makes Or Breaks Clinical AI
What makes AI effective in clinical trials? See how a top 5 pharma sponsor achieved a 62% reduction in CRA task time and 99% document classification accuracy by prioritizing clinical fluency.
-
A Day In The Life Of A Clinical Research Site
Clinical research site coordinators are the unsung heroes of trial execution—managing complex protocols, supporting participants, and navigating fragmented systems, all while ensuring study integrity.
-
Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call3/21/2025
Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.
-
Helping Sites Get Paid Frequently, Accurately, And With Full Visibility8/5/2026
By streamlining both automated and site-submitted invoicing workflows, this platform removes administrative friction, keeping the focus on trial progress and participant care.
-
On-Demand Service Models Improve Clinical Trials12/8/2025
As consumers increasingly expect convenience and immediacy, the on-demand model continues to reshape how services are delivered across nearly every sector.
-
Beyond A Single Disease: Traversing Complexity In Breast Cancer Clinical Development9/8/2026
Biomarkers, new therapies, and tough enrollment hurdles are reshaping breast cancer trials. Get the insights to plan smarter.
-
The Answer To Advance Your Allogeneic CAR-T Cell Clinical Trial9/29/2026
Dozens of assays, a shifting sample analysis plan, and a network of specialty labs: see how coordinated oversight kept an allogeneic CAR-T trial on track.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.
-
Learn about the benefits of a Late Stage Customization approach, including how it can support a leaner, more responsive supply chain, ensuring life-changing therapies reach patients more efficiently.
-
Integrated human ADME studies streamline the process from 14C synthesis to clinical conduct and final reporting to accelerate your drug development program.
-
Whether you're aiming to run a pivotal trial or multiple studies, discover how Veristat's full-service support can drive your biologic therapies from inception to market success.